Cargando…
Long-term high-dose cholecalciferol in patients with heavy proteinuria
Four patients presenting with heavy proteinuria, vitamin D deficiency and secondary hyperparathyroidism were treated with cholecalciferol for 1.5–3 years. Doses of 7143–14286 U/day were necessary to achieve the calcidiol target of >75 nmol/L. The effect of dosing on calcidiol levels was inconsist...
Autor principal: | Singer, Richard F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421739/ https://www.ncbi.nlm.nih.gov/pubmed/25984177 http://dx.doi.org/10.1093/ndtplus/sfr082 |
Ejemplares similares
-
Proteinuria and glomerular injury associated with the anti-angiogenesis drug Vargatef™
por: Manjunath, Veena, et al.
Publicado: (2011) -
Proteinuria in Diabetes
por: Thomas, Stephen, et al.
Publicado: (2000) -
Long-Term Cholecalciferol Administration in Hemodialysis Patients: A Single-Center Randomized Pilot Study
por: Mieczkowski, Mariusz, et al.
Publicado: (2014) -
Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol
por: Wylon, Katharina, et al.
Publicado: (2017) -
Oral Postdialysis Cholecalciferol Supplementation in Patients on Maintenance Hemodialysis: A Dose-Response Approach
por: Descombes, Eric, et al.
Publicado: (2014)